Guzman y Gomez Limited (ASX:GYG) Responds to ASX Compliance Inquiry on Half-Year Earnings
Guzman y Gomez Limited (ASX:GYG) confirms its half-year earnings aligned with market expectations in response to ASX compliance inquiry.
Tag: Earnings Reports
Clean Seas Seafood (ASX:CSS) Announces 1H FY25 Results
Clean Seas Seafood (ASX:CSS) reports a 10.4% revenue decline in 1H FY25 and announces a potential merger with Yumbah Aquaculture.
Xamble Group Limited (ASX:XGL) Reports Year-End Financial Results
Xamble Group Limited (ASX:XGL) reports a 15% revenue decline and a 16% increase in net loss for the year ended 31 December 2024.
Generation Development Group Limited (ASX:GDG) Reports Half Year Financial Results
Generation Development Group Limited (ASX:GDG) reports a 155% increase in revenue and a 1,699% rise in net profit for the half-year ended 31 December 2024.
PainChek Limited (ASX:PCK) Releases Half Year Results
PainChek Limited (ASX:PCK) reports a 27% revenue increase in its half-year results, highlighting growth and expansion into the US market.
Vection Technologies (ASX:VR1) Accelerates Path to Profitability with Strong 1H25 Results
Vection Technologies (ASX:VR1) reports a 15% revenue increase in 1H25 and significant EBITDA improvement, accelerating towards profitability.
The Hydration Pharmaceuticals Company Limited (ASX:HPC) Reports FY2024 Financial Results
The Hydration Pharmaceuticals Company Limited (ASX:HPC) reports a 25.5% revenue decline in FY2024, asset divestiture, and a strategic focus on US growth.
TasFoods Ltd (ASX:TFL) Announces FY2024 Results
TasFoods Ltd (ASX:TFL) reports FY2024 results, showing improved EBITDA, cost reductions, and expansion in Pet Treats and Pyengana Dairy segments.
Ariadne Australia Limited (ASX:ARA) Reports 62.5% Revenue Growth and Declares Interim Dividend
Ariadne Australia Limited (ASX:ARA) reports a 62.5% revenue increase and declares a fully franked interim dividend.
Epsilon Healthcare (ASX:EPN) Reports 43% Revenue Growth and Significant Loss Reduction for 2023
Epsilon Healthcare (ASX:EPN) reports a 43% revenue increase and a 92% reduction in net loss for 2023, alongside entering Voluntary Administration.